Our findings reveal that LRP1B is also frequently interrupted by SV breakpoints in NKTCL, notably to a much larger extent in relapsed/refractory patients (6.9% in primary versus 30.8% in relapsed/refractory; Fisher’s exact test, P = 0.034). This evidence concerns the gene LRP1B and extranodal nasal NK/T cell lymphoma.